feed,title,long_url,short_url
Motley,Better Biotech Stock: CRISPR Therapeutics or Twist Bioscience?,https://www.fool.com/investing/2022/01/28/better-biotech-stock-crispr-therapeutics-or-twist/?source=iedfolrf0000001,https://bit.ly/3IFLqaw
Motley,This Under-the-Radar SPAC Stock Is Quietly Crushing the Market. Is It a Buy in 2022?,https://www.fool.com/investing/2022/01/28/this-under-the-radar-spac-stock-is-quietly-crushin/?source=iedfolrf0000001,https://bit.ly/3G2TnoI
